Under QIP issue
Nath Bio-Genes (India) announced that the QIP Committee of Board of Directors of the Company has approved the allotment of 30 lakh equity shares of face value of Rs 10 each at a premium of Rs 445 per equity shares aggregating to Rs 136.50 crore.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
